Library

CB-13

CB-13 is classified as Cannabinoid agonist (CB₁/CB₂). It belongs to the Synthetic cannabinoid (peripherally-restricted 1,1-diaryl-piperazine amide) chemical class.

Also known as: SAB-378

Classification

  • Chemical: Cannabinoid

Effects

  • Muscle Relaxation
  • Pain Relief
  • Tingling
  • Physical Comfort
  • Sedation
  • Dry Mouth
  • Anxiety Suppression
  • Drowsiness
  • Euphoria

Routes of Administration

Oral

Dosage

  • Heavy: 450 mg + (not recommended)
  • Light: 75 – 150 mg
  • Common: 150 – 300 mg
  • Strong: 300 – 450 mg
  • Threshold: 50 mg

Duration

  • Onset: 0.5-1.5 h
  • Peak: 2-4 h
  • Offset: 4-8 h
  • After Effects: 2-6 h
  • Total Duration: 6-10 h

Vaporized

Dosage

  • Heavy: > 50 mg (little additional effect)
  • Light: 10 – 15 mg
  • Common: 15 – 30 mg (inefficient)
  • Strong: 30 – 50 mg
  • Threshold: 5 mg

Duration

  • Onset: 0.02-0.08 h
  • Peak: 0.5-1.5 h
  • Offset: 1-2 h
  • After Effects: 1-3 h
  • Total Duration: 3-5 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

No external data sources listed for this substance yet.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

CB-13 - DrugsPRO aineopas

CB-13: CB-13 is classified as Cannabinoid agonist (CB₁/CB₂). It belongs to the Synthetic cannabinoid (peripherally-restricted 1,1-diaryl-piperazine amide) chemical class.

Related pages